United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-3073_0d5d8d59-324c-4cf7-bc19-bc4d208bef05
- Product NDC
- 71335-3073
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100412
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-0) · 71335-3073-0
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-1) · 71335-3073-1
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-2) · 71335-3073-2
- 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-3) · 71335-3073-3
- 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-4) · 71335-3073-4
- 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-5) · 71335-3073-5
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-6) · 71335-3073-6
- 12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-7) · 71335-3073-7
- 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-8) · 71335-3073-8
- 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-9) · 71335-3073-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →